U.S. market Open. Closes in 4 hours 14 minutes

TCRT | Alaunos Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue5.00K2.92M398.00KN/AN/A146.00K6.39M6.86M4.33M1.37M800.00K800.00K667.00KN/AN/AN/AN/AN/AN/AN/AN/A2.57K1.73K
Cost of Revenue2.31M2.76M740.00K1.13M629.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-2.31M163.00K-342.00K-1.13M-629.00K146.00KN/AN/A4.33M1.37M800.00K800.00K667.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses26.18M38.16M77.21M80.36M57.86M54.05M59.88M172.17M124.43M44.87M58.51M102.97M72.07M24.55M12.12M25.62M28.57M19.11M9.79M39.17K35.84K42.51K74.26K
Selling, General & Admin9.90M13.14M27.56M27.66M19.53M19.92M14.80M14.38M17.65M12.17M15.66M19.52M14.98M11.64M7.57M8.37M9.58M8.72M4.19M39.17K35.36KN/A120.00
Research & Development16.28M25.02M49.64M52.70M38.33M34.13M45.08M157.79M106.78M32.71M42.85M83.45M57.08M12.91M4.56M17.25M18.99M10.39M5.59MN/AN/AN/AN/A
Other Operating Expenses1.05M529.00K-1.20M385.00K813.00K631.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A486.0042.51K74.14K
Operating Income-28.49M-35.10M-77.55M-80.36M2.26M-53.91M-53.49M-165.31M-120.10M-43.50M-57.71M-102.17M-71.40M-24.55M-12.12M-25.62M-28.57M-19.11M-9.79M-39.17K-35.84K-39.94K-72.53K
Other Expenses / Income-6.65M-2.62M-1.20M385.00K-120.06M789.00K-830.00K10.00K12.00K11.72M606.00K6.04M7.62M-8.12M4.47MN/AN/AN/AN/AN/AN/AN/AN/A
Before Tax Income-35.14M-37.73M-78.75M-79.98M-117.80M-53.12M-54.32M-165.30M-120.09M-31.78M-57.11M-96.13MN/AN/AN/AN/AN/AN/AN/A-39.17K-35.84K-39.94K-72.53K
Income Tax Expenses2.15M-133.00K-1.86M-1.13M60.12M-947.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-35.14M-37.60M-76.89M-78.85M-177.92M-53.12M-54.32M-165.30M-120.09M-31.78M-57.11M-96.13M-63.78M-32.67M-7.65M-25.23M-26.61M-17.86M-9.52M-39.17K-35.84K-39.94K-72.53K
Interest Expenses1.92M3.15M1.18MN/AN/A-789.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding16.00M14.48M14.29M13.98M11.20M143.51M136.94M130.39M125.42M101.13M85.94M78.55M66.00M46.00M23.11M21.23M18.83M12.57M4.10M135.99K116.82K112.48K90.27K
Diluted Shares Outstanding16.00M14.48M14.29M13.98M11.20M143.71M136.94M130.39M125.42M101.13M85.94M78.55M66.00M46.00M23.11M21.23M18.83M12.57M4.10M135.99K116.82K112.48K90.27K
EBITDA-26.18M-34.71M-76.07M-80.36M2.89M-54.06M-53.95M-165.01M-119.73M-31.32M-56.37M-95.47M-63.51M-16.23M-16.27M-25.23M-28.14M-18.94M-9.69M-39.17K-35.36K-39.14K-71.78K
EBITDA Margin-523,560.00%-1,187.85%-19,112.81%0.00%0.00%-37,030.14%-844.48%-2,405.00%-2,763.87%-2,281.06%-7,046.13%-11,934.25%-9,521.74%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,523.04%-4,159.04%
EBIT-31.07M-34.58M-77.57M-79.98M-117.80M-54.85M-54.32M-165.30M-120.09M-31.78M-57.11M-96.13M-63.78M-32.67M-7.65M-25.23M-26.61M-17.86M-9.52M-39.17K-35.84K-39.94K-72.53K
EBIT Margin-621,437.90%-1,183.30%-19,489.70%0.00%0.00%-37,570.55%-850.26%-2,409.23%-2,772.11%-2,314.71%-7,138.38%-12,016.50%-9,561.92%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,554.12%-4,202.49%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙